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DEAN’S RESEARCH NEWSLETTER                          Summer 2020
It is my pleasure to share the latest edition of the research newsletter that includes updates on 
a number of important faculty and student research projects on COVID-19 and other topics from 
across New York Medical College (NYMC). As we continue to learn more about COVID-19, I am 
encouraged that this research will provide valuable insight towards the development of treatments 
and public health strategies to address not just this pandemic, but future pandemics as well. I 
hope that the work reported here inspires you as much as it does me. I look forward to sharing 
more updates in future issues. 
Supporting research for our faculty and students remains one of the major priorities at NYMC. 
So I am gratified to see that, despite the difficult times, more than 100 students are participating 
in research this summer and that many faculty mentors have taken advantage of the incentive 
program we established, which offers stipends of up to $1,000 for faculty mentors to work with 
our students. These stipends can then be used in mentors’ budgets to support student professional development and activities. 
Congratulations to everyone as you continue your research, collaborations and success in securing grants. I look forward to 
hearing the results. Be safe and well. 
Recommended Articles
Clinician Collaboration Key to Proning ARDS Patients
Healthcare Purchasing News
Armeen D. Poor, M.D., clinical assistant professor of medicine
What Are Resveratrol Supplements—
And Do They Have Any Health Benefits?
Women’s Health
Marina K. Holz, Ph.D., dean of the Graduate School of Basic 
Medical Sciences and professor of cell biology and anatomy
Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine    
Professor of Medicine and Pharmacology
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COVID-19 RESEARCH
Research on Rapid Diagnostic Test for COVID-19 Underway at NYMC 
Since the COVID-19 pandemic began, researchers around the world 
have been working to develop a rapid diagnostic approach to test for 
the highly infectious severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2). Research is now underway at NYMC to validate a novel 
rapid diagnostic approach to track the presence of SARS-CoV-2 and 
diagnose COVID-19 using a colorimetric reverse transcription loop-
mediated isothermal amplification (RT-LAMP) that will provide accurate 
detection of SARS-CoV-2 RNA within 30 minutes. 
The study, which is being done in collaboration with Weill Cornell 
Medicine, is an expansion of an earlier project  in which a group at 
Cornell, including Ebrahim Afshinnekoo, School of Medicine (SOM) 
Class of 2021, designed and optimized a rapid LAMP assay to detect 
SARS-CoV-2 infection from nasopharyngeal (NP) swab specimens and 
oropharyngeal (OP) swab lysates in specimens taken from COVID-19 
patients at New York-Presbyterian/Weill Cornell Medical Center. The work has now expanded to validate the method across 
several different clinical sites, including NYMC, Medical College of Wisconsin, Columbia University and Weill Cornell Medicine, 
with Mr. Afshinnekoo leading the coordination across all sites. With the assay already proven to be effective on NP and OP swabs, 
testing on saliva samples is now being done and if successful could lead to easier, more widespread testing. 
In addition to Mr. Afshinnekoo, Humayun K. Islam, M.D., Ph.D., interim chair of the Department of Pathology and clinical professor 
of pathology, will serve as principal investigator of the study, Jerry L. Nadler, M.D., dean of the SOM and professor of medicine 
and pharmacology, and Lori W. Solomon, M.D. ’99, M.P.H. ’09, chair of the Department of Family and Community Medicine 
and assistant professor of family and community medicine, will serve as co-investigators and Melinee D’Silva, M.S., laboratory 
manager in Dean Nadler’s lab, will assist with collection and preparation.
“Once cleared as a clinical diagnostic assay, the LAMP test has potential to be integral to the SARS-CoV-2 testing platform at 
NYMC, its various clinical sites and the Touro College and University System at large and will establish NYMC as one of the few 
sites in the U.S. developing a rapid test using saliva,” says Dr. Nadler. 
From left: Humayun K. Islam, M.D., Ph.D., Mari Lillis, 
Lori W. Solomon, M.D.’ 99, M.P.H.’ 09, Melinee D’Silva, M.S., 
Ebrahim Afshinnekoo, B.A., and Jerry L. Nadler, M.D.
Psychiatry Faculty Publish on Potential New Condition – COVID-19 Psychosis
  
Several members of the faculty in the Department of Psychiatry and Behavioral 
Sciences—Stephen J. Ferrando, M.D., The Edith Har-esh, M.D., Professor 
and Chair; Lidia Klepacz, M.D., assistant professor; Mohammad Tavakkoli, 
M.D., clinical assistant professor; Rhea L. Dornbush, Ph.D., professor; Reena 
Baharani, M.D., clinical assistant professor; Yvette L. Smolin, M.D., clinical 
assistant professor; and Abraham S. Bartell, M.D., M.B.A., clinical associate 
professor—as well as Sean Lynch, SOM Class of 2021, were recently published 
in Psychosomatics  (May 2020) on a potential new condition, COVID-19 
psychosis. 
“Prior reports from the 2003 SARS CoV-1 epidemic identified a range of psychiatric complications in affected patients with SARS 
(Severe Acute Respiratory Syndrome), including adjustment-related anxiety, depression, suicidal ideation, as well as organic 
hallucinosis and organic manic disorder,” says Dr. Ferrando and colleagues. “However, to date, there are few reports describing 
psychiatric symptoms associated with the COVID-19 pandemic.” Read the full article on potential new psychiatric condition.
New Chair of Medicine Co-Authors Study Finding Hydroxychloroquine 
Ineffective for Treating COVID-19
Hydroxychloroquine has been widely administered to COVID-19 patients 
but with little scientific evidence to support its use. Neil Schluger, M.D., who 
has just joined NYMC as chair of the Department of Medicine and director 
of medical services at Westchester Medical Center (WMC), has co-authored 
one of the most robust studies to date into the use of hydroxychloroquine for 
treating COVID-19 infection. Results, recently published in The New England 
Journal of Medicine, demonstrate that patients who received the drug did not 
fare any better than patients who did not receive it.
“These results come at a pivotal time as medical professionals and scientists 
everywhere are working diligently to find effective treatments for the 
SARS-CoV-2 virus,” says Dr. Schluger. “As new treatments are tested and 
administered, we must continue to evaluate their effects in larger scale studies and trials to form a more targeted and effective 
patient care regimen.”
The study included the first 1,376 patients hospitalized with COVID-19 at a large New York City medical center (excluding 
patients who were discharged, intubated or died within 24 hours of arriving at the emergency department). Among these 
patients, 811 received hydroxychloroquine and 565 patients did not. The researchers examined the relationship between 
hydroxychloroquine use and the development of respiratory failure that led to intubation or death. Overall, 346 patients 
developed respiratory failure; 180 were intubated and 166 died without intubation. 
After using established and sophisticated statistical techniques to account for known differences between patients in the two 
groups, including age, sex and initial vital signs, Dr. Schluger and the other researchers found that patients who received 
hydroxychloroquine had the same risk of intubation or death as patients who did not receive the drug.
“Before our study was published, hydroxychloroquine was being widely used to treat patients with COVID-19 infection. The 
findings supported the National Institutes of Health guidance that hospitalized COVID-19 patients should not be treated 
routinely with hydroxychloroquine, though that guidance was being widely ignored. Our study has since been confirmed by 
other groups. We need to urgently search for more effective therapies for this infection.” Read the full article on Dr. Schluger’s 
research. 
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Neil Schluger, M.D. (second from left) and colleagues at 
Tikur Anbessa (Black Lion) Hospital in Ethiopia in 2017
Examining the COVID-19 Health Disparity for Black and Latinx Populations 
Subject of Student Commentary
With the disproportionate morbidity and mortality of Black and Latinx populations 
during the COVID-19 pandemic not easily explained given the limited reported 
data, Dylan Macciola, SOM Class of 2023, and Zafar Karimov, SOM Class of 
2023, recently commenced a study to explore two concepts known to play a large 
role in the delivery of health care—implicit bias and social determinants of health 
—and examine how they factor into the current health crisis. 
“In March, during one of New York Governor Andrew Cuomo’s daily briefings, he 
highlighted the initial state-reported data that suggested that African American 
and Latinx populations across the country were disproportionately suffering worse 
complications of coronavirus infection and he posed the question of why this was occurring. We sought to try to answer this 
question for ourselves,” say Mr. Macciola and Mr. Karimov. Read the full article on student commentary.
Dylan Macciola and Zafar Karimov
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Faculty Showcase Innovative Way to Achieve Safe Lung Deflation
Draginja R. Cvetkovic, M.D., clinical associate professor of anesthesiology, 
and Tracey L. Weigel, M.D., clinical professor of surgery, received the “Case 
Report of the Month” distinction by the journal Anesthesia Analgesia Practice 
in May for their report on the use of one-lung ventilation to mitigate the risk 
of infection transmission to health care personnel. 
“Airway management is an aerosol-producing high-risk procedure. With the 
current COVID-19 pandemic, care must be taken to prevent aerosolization 
of these viral particles,” according to Drs. Cvetkovic and Weigel. “One-lung 
ventilation (OLV) is a technique widely used to improve surgical exposure 
during intrathoracic surgical procedures.” While traditionally OLV is 
accomplished using a double-lumen tube (DLT) or a bronchial blocker (BB) 
facilitating ventilation to the desired lung, in the case reported on by Drs. 
Cvetkovic and Weigel, the use of a laparoscopy smoke evacuation system 
was used to safely deflate the lung without exposing operating room personnel to aerosolization particles.
Center for Disaster Medicine Uses Team Research Model to Examine 
COVID-19 Response 
In recent months, as the COVID-19 outbreak has continued to grow, government and 
public health officials have struggled to address the global health crisis. With still so 
much unknown about the virus and science scrambling to catch up, officials have 
looked to data and research from past pandemics and public health emergencies to 
inform their response to COVID-19. So, what lessons learned from past pandemics 
have proved beneficial in addressing the COVID-19 pandemic? And what has been 
learned from this pandemic that can be used to improve emergency preparedness 
and public health strategy for future pandemics?
The Center for Disaster Medicine (CDM) at NYMC recently set out to gather answers 
to these questions and more. To accommodate the dozens of medical students who 
sought to be involved in COVID-19 research, the CDM deployed a team research 
model with several research teams. Each team, made up of students and a faculty 
mentor, was tasked with investigating a specific area important to the response to 
COVID-19 that would ultimately allow motivated students to submit their work for 
presentation at a national meeting or for publication in a peer-reviewed journal. 
“The CDM is such an awesome part of NYMC and I jumped at the opportunity to get involved with research there so that I 
could contribute to the growing literature and knowledge about COVID-19 in a meaningful way,” says Abigail Marriott, SOM 
Class of 2023.
“I first got involved with the CDM because I saw great potential in researching COVID-19 and knew there was tremendous 
merit in unraveling the many mysteries this pandemic brings—especially why the U.S. has fallen behind other similarly 
developed nations in terms of flattening the curve,” says Lee Hecht, SOM Class of 2023. “The knowledge we’ve accumulated 
regarding public health endeavors and their effectiveness in combating pandemics over the last century is vast, and so 
consolidating it into one publication will prove to be a challenge, but I’m excited to see where it takes us!” Read the full article 
about CDM team research projects. 
 
During the 1918 pandemic, the government 
also encouraged masks, outlawed public 
gatherings and cancelled school. Photo credit: 
National Archives.
The laparascopy smoke evacuation system with the 
arrow indicating the direct connection between the filter 
tubing and the tracheal port of the double-lumen 
tube without the need for an adapter. 
Department of Obstetrics and Gynecology Turns to Research 
During Pandemic
As COVID-19 became an abrupt new reality, the Department of Obstetrics and Gynecology turned to research with impressive 
results. With 14 protocols submitted to the NYMC Institutional Review Board (IRB) to date, four studies are already underway, 
three papers have been accepted and two already published. 
“In the first weeks of the shutdown, we initiated twice weekly Zoom research meetings to encourage and nurture participation 
in research. These meetings were open to all department faculty, residents and any interested medical students,” says Sean 
S.Tedjarati, M.D., M.P.H., M.B.A., chair and clinical professor of obstetrics and gynecology. “I am very proud of the hard work 
and commitment demonstrated by the faculty, our residents and students and the significant results speak for themselves.”
A “Guide for Urogynecologic Patient Care Utilizing Telemedicine During the COVID-19 Pandemic: Review of Existing 
Evidence,” was co-authored by Cara Grimes, M.D., M.A.S., associate professor of obstetrics and gynecology and urology, in 
International Urogynecology in April.
In June, Camille A. Clare, M.D., M.P.H. ’11, associate dean of diversity and inclusion and associate professor of obstetrics 
and gynecology, along with three obstetrics and gynecology residents, Itamar Futterman, M.D., Liel Navi, M.D., and Miriam 
Toaff, M.D., co-authored a case series on “COVID19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients” in the 
American Journal of Perinatology Reports. The case series described two gravid patients who tested positive for COVID-19 
and had laboratory findings that mimicked hemolysis, elevated liver enzymes and low platelets syndrome (HELLP).  Read the 
full article on department research.
5
SOM Students Participate in Research Projects at 
NYC Health + Hospitals/Metropolitan
Over the course of the last few months, 15 SOM students have been 
collecting data for three COVID-19 related research projects at NYMC 
affiliate NYC Health + Hospitals/Metropolitan (MHC).
“During this pandemic, we have seen the toll this disease takes on the 
health care field. In response, my fellow students and I have devoted many 
hours to help conduct these research studies in the hope of adding to the 
growing volume of literature on COVID-19,” says Bertie Zhang, SOM Class 
of 2021, who coordinated the volunteers for the three projects at MHC.  
“Though we have been confined at home, we have been able to assist in 
the data collection process, freeing up the time of attending physicians and residents. The data we collect will assist in the 
development of treatments and medications that can help humanity overcome this terrible disease. It is truly awe-inspiring to 
be a part of public health history in the making and to help contribute to scientific discovery, however we can.”
Nora Bergasa, M.D., professor of medicine and chair of Department of Medicine at MHC, is leading a team of students to 
create a comprehensive database of COVID-19 patients admitted to the hospital for use in an epidemiological study. Getaw 
Worku Hassen, M.D., Ph.D., professor of emergency medicine, is leading a team of students who are reviewing charts, 
blood work and imaging studies, as well as conducting follow-up calls to patients for a quality improvement project to assess 
the disposition of patients who were seen in the medical screening annex and discharged. Samrina Kahlon, M.D., clinical 
assistant professor of emergency medicine, and her team of students are actively conducting chart review and data analysis 
as part of a multicenter COVID-19 study assessing potential factors correlating to the severity of the disease. Read the full 
article on research projects at MHC. 
Grants Corner
Roberto Camillo M. Bergamaschi, M.D., Ph.D., professor of surgery, has received a $263,813 grant from THD America 
for “Multi-center, Non-randomized Prospective Observation Study Comparing Ferguson Hemorrhoidectomy and Transanal 
Hemorrhoidal Deaterialization (THD) for Prolapsed, Nonincarcerated, Reducible Hemorrhoids In Terms of One-Year 
Recurrence.”
Mitchell S. Cairo, M.D., professor of pediatrics, pathology, microbiology and immunology, medicine and cell biology and 
anatomy, has received a $1,276,171 grant from Nektar Therapeutics for a “Phase 1, Open-label, Multi-center, Dose-escalation 
and Dose-expansion Study of NKTR-255 as a Single Agent in Relapsed or Refractory Hematological Malignancies and in 
Combination with Daratumumab as a Salvage Regimen for Multiple Myeloma.” 
Thomas Diflo, M.D., professor of surgery, and Daniel G. Glicklich, M.D., professor of medicine, have received a $180,485 
grant from Natera for “The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry.”
Sankaran S. Krishnan, M.D., M.P.H., associate professor of clinical pediatrics, has received a $97,882 grant from Astra 
Zeneca for “The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment 
Patterns and Health Outcomes of Individuals with Severe Asthma in the United States.”
Dana G. Mordue, Ph.D., associate professor of microbiology and immunology, has received a $442,661 grant from the 
U.S. Army for “Analysis of the Peripheral Blood Transcriptome to Identity Clinical Correlates of Pathology in Patients with 
Babesiosis.” 
Jerry L. Nadler, M.D., dean of SOM and professor of medicine and pharmacology, has received a $804,755 grant from the 
NIH for “Role of 12-lipoxygenase and 12-HETE signaling beta-cell dysfunction.” The project is done in collaboration with 
Ercument Dirice, Ph.D., assistant professor of pharmacology, who was recruited from the Joslin Diabetes Center, Harvard 
Medical School. The study is a continuation of a long-term collaboration with Raghu Mirmira, M.D., Ph.D., professor of 
medicine at the University of Chicago, to develop new anti-inflammatory treatments for type 1 and type 2 diabetes. 
Lance A. Parton, M.D., professor of pediatrics and associate professor of anesthesiology and obstetrics and gynecology, 
has received a $38,496 grant from Infant Bacterial Therapeutics AB for a “randomized, double blind, parallel-group, placebo-
controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention 
of necrotizing enterocolitis-The Connection study.”
Raj K. Tiwari, Ph.D., interim chair of Department of Microbiology and Immunology, professor of microbiology and immunology 
and associate professor of otolaryngology, has received a $195,876 grant from NYC Health + Hospitals/PAGNY for “Genetic 
Profiling of Melanoma for Immunotherapy.”
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Study Offers Important Insight on How Brain Regulates Sleep and Waking 
Chronic or intermittent sleep disorders, including narcolepsy, rapid eye movement 
(REM) sleep behavior disorder, sleep apnea and insomnia, afflict nearly 50 to 70 
million people in the United States. Yet the neural mechanisms controlling both normal 
sleep and its pathologies remain poorly understood. Inhibitory neurons are found 
throughout the brain where they generate rhythmical brain activity seen during waking 
and sleeping states and prevent run-away excitation, which can lead to seizures.
In a recent study, Christopher Leonard, Ph.D., interim chair and professor of 
physiology, and Masaru Ishibashi, Ph.D., adjunct assistant professor, working in 
conjunction with Barbara Jones, Ph.D., professor at the Montreal Neurological Sciences and Antoine Adamantides, Ph.D., 
professor at the University of Bern, used optogenetic methods to identify and then to selectively stimulate a group of inhibitory 
neurons in the brainstem that were long-known to be intermingled with modulatory cholinergic neurons, but whose function 
were unknown. Read full article on Dr. Leonard’s study.
GRANTS & DEPARTMENT RESEARCH
Research Information Updates/NIH Links 
Weekly NIH Announcements and NIH Funding Opportunities 
Learn more about the National Academy of Sciences, Engineering, and Medicine Research Associateship Program
NYMC Office of Research Administration: Learn more about funding opportunities here. 
Faculty Publications 
NYMC faculty are notable scholars and researchers who are published in leading journals across a wide range of health 
science disciplines. This listing represents just a small sample of recent publications.
Nader G. Abraham, Ph.D., professor of medicine and pharmacology, published “Genetic Polymorphisms Complicate 
COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm” in Antioxidants. Dr. Abraham and John A. McClung, M.D., 
professor of medicine, published “Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular 
Disease” in Antioxidants & Redox Signaling. 
Chirag D. Gandhi, M.D., M.S., chair and professor of neurosurgery, professor of neurology and radiology, Ida Azizkhanian, 
M.D. ’20, Benjamin Epstein, M.D. ’20, Abhiniti Mittal, M.D. ’20, Nam Lee, M.D. ’19, Justin G. Santarelli, M.D., assistant 
professor of neurosurgery, Fawaz Al-Mufti, M.D., assistant professor of neurology, and Christian A. Bowers, M.D., assistant 
professor of neurosurgery, published “Frailty and Spontaneous Intracerebral Hemorrhage: Does The Modified Frailty Index 
Predict Mortality?” in Clinical Neurology and Neurosurgery.
Alan L. Gass, M.D., professor of medicine, and Gregg M. Lanier, M.D., associate professor of medicine, published 
“Mineralocorticoid Receptor Antagonist Use in Heart Failure with Reduced Ejection Fraction and End-Stage Renal Disease 
Patients on Dialysis A Literature Review,”  in Cardiology in Review. 
Michael H. Gewitz, M.D., vice chair and professor of pediatrics, was a co-investigator on “Multisystem Inflammatory 
Syndrome in Children in New York State” recently published in The New England Journal of Medicine. 
Aaqib H. Malik, M.D., M.P.H., clinical assistant professor of medicine, Michael D. Goldberg, M.D., assistant professor of 
medicine, Diwakar Jain, M.D., professor of medicine, William H. Frishman, M.D., professor of medicine and pharmacology, 
and Wilbert S. Aronow, M.D., professor of medicine., published “Cardiovascular Outcomes with the Use of Sodium-Glucose 
Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease an Updated Meta-Analysis of 
Randomized Controlled Trials” in Cardiology in Review. 
Irim Salik, M.D., assistant professor of anesthesiology, Gerald Zaidman, M.D., professor of clinical ophthalmology, and 
Samuel Barst. M.D., clinical associate professor of anesthesiology, published “Peters Anomaly: A 5-year Experience”  in 
Pediatric Anesthesia.
Aalok Singh, M.D., assistant professor of pediatrics, and Simon Li, M.D., M.P.H., associate professor of pediatrics, published 
“Multisystem Inflammatory Syndrome in U.S. Children and Adolescents” in The New England Journal of Medicine.
Virendra Tewari, M.D., assistant professor of medicine, and Edward Lebovics. M.D., Sarah C. Upham Professor of 
Gastroenterology and professor of medicine, published “National Landscape of Unplanned 30-Day Readmission Rates for 
Acute Non-Hemorrhagic Diverticulitis: Insight from National Readmission Database”  in Digestive Diseases & Sciences. 
Richard J. Zeman, Ph.D., associate professor of cell biology and anatomy, Chitti R. Moorthy, M.D., chair and professor 
of clinical radiation medicine, and Joseph D. Etlinger, Ph.D., chair and professor of cell biology and anatomy, published 
“Therapeutic Target for External Beam x-Irradiation in Experimental Spinal Cord Injury”  in the Journal of Neurosurgery-Spine. 
See full list of recent Faculty Publications.
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